SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about appointment of CFO

03 Nov 2017 Evaluate

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that the Board at its Meeting held on November 2, 2017 has approved the appointment of V. S. Mani as President & Global Chief Financial Officer with effect from November 16, 2017 upon the recommendation of the Nomination and Remuneration Committee. P Ganesh, current President and Global Chief Financial Officer, has tendered his resignation to explore an opportunity outside the Company. The Board places on record its appreciation for contribution made by P Ganesh.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2422.75 30.15 (1.26%)
05-May-2026 13:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.40
Dr. Reddys Lab 1270.80
Cipla 1327.05
Zydus Lifesciences 910.40
Lupin 2346.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×